The pharmacokinetics of FCE 22101 were studied in rats, rabbits, Cynomolgus monkeys and dogs after intravenous administration. Pertinent phannacokinetic parameters were determined according to a two-compartment model and correlated among species as an exponential function of body weight, thereby allowing an estimation of phannacokinetic parameters corresponding to a 70 kg man. Allometric equations, including data on humans reported in the literature, were also established and used to study similarities and differences in the disposition of FCE 22101 among species. The phannacokinetic profile of FCE 22101 was consistent with the princi-ples of allometry in all animal species studied (and in man) with the exception of the Cynomolgus monkey, i...
This is the first report of the project 'Selection of species and interspecies differences in relati...
To predict human pharmacokinetics such as the clearance and the plasma concentration profile of a ne...
One of the fundamental challenges drug metabolism scientists face in drug discovery and development ...
The pharmacokinetic properties of SCE-2787 administered intravenously at a dose of 20 mg/kg of body ...
Accepted for publication 3000-kg elephant. Despite this 10 * range in weight, most land mammals have...
Background: To optimize antimicrobial dosing in different animal species, pharmacokinetic informatio...
Background: To optimize antimicrobial dosing in different animal species, pharmacokinetic informatio...
Plasma pharmacokinetics of ST-246, smallpox therapeutic, was evaluated in mice, rabbits, monkeys and...
BACKGROUND: To optimize antimicrobial dosing in different animal species, pharmacokinetic informatio...
BACKGROUND: To optimize antimicrobial dosing in different animal species, pharmacokinetic informatio...
F(ab*)2 fragments are sometimes preferred to whole IgG for therapeutic or diagnostic uses. Preclinic...
Since the advent of the modern era of antimicrobial chemotherapy in the 1930s, animal infection mode...
<p>Background: To optimize antimicrobial dosing in different animal species, pharmacokinetic informa...
The association between physiologically dependent pharmacokinetic parameters (CLB, T1/2β, Vdss) of m...
The association between physiologically dependent pharmacokinetic parameters (CLB, T1/2β, Vdss) of m...
This is the first report of the project 'Selection of species and interspecies differences in relati...
To predict human pharmacokinetics such as the clearance and the plasma concentration profile of a ne...
One of the fundamental challenges drug metabolism scientists face in drug discovery and development ...
The pharmacokinetic properties of SCE-2787 administered intravenously at a dose of 20 mg/kg of body ...
Accepted for publication 3000-kg elephant. Despite this 10 * range in weight, most land mammals have...
Background: To optimize antimicrobial dosing in different animal species, pharmacokinetic informatio...
Background: To optimize antimicrobial dosing in different animal species, pharmacokinetic informatio...
Plasma pharmacokinetics of ST-246, smallpox therapeutic, was evaluated in mice, rabbits, monkeys and...
BACKGROUND: To optimize antimicrobial dosing in different animal species, pharmacokinetic informatio...
BACKGROUND: To optimize antimicrobial dosing in different animal species, pharmacokinetic informatio...
F(ab*)2 fragments are sometimes preferred to whole IgG for therapeutic or diagnostic uses. Preclinic...
Since the advent of the modern era of antimicrobial chemotherapy in the 1930s, animal infection mode...
<p>Background: To optimize antimicrobial dosing in different animal species, pharmacokinetic informa...
The association between physiologically dependent pharmacokinetic parameters (CLB, T1/2β, Vdss) of m...
The association between physiologically dependent pharmacokinetic parameters (CLB, T1/2β, Vdss) of m...
This is the first report of the project 'Selection of species and interspecies differences in relati...
To predict human pharmacokinetics such as the clearance and the plasma concentration profile of a ne...
One of the fundamental challenges drug metabolism scientists face in drug discovery and development ...